NO20043101L - Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet - Google Patents
Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighetInfo
- Publication number
- NO20043101L NO20043101L NO20043101A NO20043101A NO20043101L NO 20043101 L NO20043101 L NO 20043101L NO 20043101 A NO20043101 A NO 20043101A NO 20043101 A NO20043101 A NO 20043101A NO 20043101 L NO20043101 L NO 20043101L
- Authority
- NO
- Norway
- Prior art keywords
- orally active
- enhanced bioavailability
- taxane derivatives
- pharmaceutical mixtures
- active taxane
- Prior art date
Links
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34288901P | 2001-12-20 | 2001-12-20 | |
| PCT/US2002/040127 WO2003053350A2 (fr) | 2001-12-20 | 2002-12-12 | Compositions pharmaceutques de derives de taxane actifs par voie buccale a biodisponibilite amelioree |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043101L true NO20043101L (no) | 2004-07-19 |
Family
ID=23343716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043101A NO20043101L (no) | 2001-12-20 | 2004-07-19 | Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030220391A1 (fr) |
| EP (1) | EP1465618A2 (fr) |
| JP (1) | JP2006501134A (fr) |
| KR (1) | KR20040066921A (fr) |
| CN (1) | CN1273130C (fr) |
| AR (1) | AR037951A1 (fr) |
| AU (1) | AU2002361701A1 (fr) |
| BR (1) | BR0215184A (fr) |
| CA (1) | CA2470826A1 (fr) |
| GE (1) | GEP20063806B (fr) |
| HR (1) | HRP20040545A2 (fr) |
| HU (1) | HUP0500843A2 (fr) |
| IL (1) | IL162118A0 (fr) |
| IS (1) | IS7306A (fr) |
| MX (1) | MXPA04005877A (fr) |
| NO (1) | NO20043101L (fr) |
| PE (1) | PE20030742A1 (fr) |
| PL (1) | PL374283A1 (fr) |
| RS (1) | RS52904A (fr) |
| RU (1) | RU2004119557A (fr) |
| TW (1) | TW200302086A (fr) |
| UY (1) | UY27598A1 (fr) |
| WO (1) | WO2003053350A2 (fr) |
| ZA (1) | ZA200404584B (fr) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005519075A (ja) * | 2002-02-25 | 2005-06-30 | リフジャスロウン エイチエフ | 吸収促進剤 |
| US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
| KR100533458B1 (ko) | 2002-07-20 | 2005-12-07 | 대화제약 주식회사 | 파클리탁셀의 가용화용 조성물 및 그의 제조 방법 |
| EP1498120A1 (fr) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Formulation semi-solide pour l'administration orale du taxol |
| PT1664033E (pt) | 2003-09-25 | 2008-01-17 | Tapestry Pharmaceuticals Inc | Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção |
| US20060088591A1 (en) * | 2004-10-22 | 2006-04-27 | Jinghua Yuan | Tablets from a poorly compressible substance |
| US20060116420A1 (en) * | 2004-11-23 | 2006-06-01 | Ramakrishnan Chidambaram | Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel |
| AU2012202903B2 (en) * | 2005-02-18 | 2014-12-11 | Abraxis Bioscience, Inc. | Drugs with improved hydrophobicity for incorporation in medical devices |
| CN105879114A (zh) * | 2005-02-18 | 2016-08-24 | 阿布拉西斯生物科学公司 | 用于整合入医疗装置的疏水性改善的药物 |
| ES2424242T3 (es) | 2005-07-15 | 2013-09-30 | Angiochem Inc. | Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos |
| US20070015834A1 (en) * | 2005-07-18 | 2007-01-18 | Moshe Flashner-Barak | Formulations of fenofibrate containing PEG/Poloxamer |
| TR200801336T1 (tr) | 2005-08-31 | 2008-08-21 | Abraxis Bioscience, Inc. | Kararlılığı artmış zayıf su çöznurluğune sahip ilaçların preparasyonuna yönelik kompozisyonlar ve yöntemler. |
| WO2007134354A1 (fr) * | 2006-05-23 | 2007-11-29 | Ebewe Pharma Ges.M.B.H. Nfg. Kg | Formulation pharmaceutique |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| WO2008121476A1 (fr) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Analogues de taxane biologiquement actifs, et procédés de traitement par administration orale |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| EP1946747A1 (fr) * | 2007-01-17 | 2008-07-23 | Sandoz AG | Composition pharmaceutique à stabilité améliorée contenant des dérivés de taxane |
| WO2008109360A1 (fr) | 2007-02-28 | 2008-09-12 | Tapestry Pharmaceuticals, Inc | Analogues de taxane pour le traitement du cancer du cerveau |
| EP2190413B1 (fr) * | 2007-08-24 | 2015-01-28 | Stichting Het Nederlands Kanker Instituut | Compositions pour le traitement des maladies néoplasiques |
| US9089544B2 (en) * | 2007-08-24 | 2015-07-28 | Slotervaart Participaties Bv | Composition |
| RU2488393C2 (ru) * | 2007-11-12 | 2013-07-27 | Новартис Аг | Жидкие композиции, включающие валсартан |
| EP2077132A1 (fr) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation |
| ES2344674B1 (es) | 2008-08-07 | 2011-06-29 | Gp Pharm, S.A. | Composicion farmaceutica inyectable de taxanos. |
| AU2009304560A1 (en) | 2008-10-15 | 2010-04-22 | Angiochem Inc. | Conjugates of GLP-1 agonists and uses thereof |
| EP2662472B1 (fr) | 2009-03-31 | 2019-02-27 | Boehringer Ingelheim International Gmbh | Procédé de revêtement d'une surface d'un composant |
| EP2432531B1 (fr) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adaptateur, dispositif d'inhalation et pulvérisateur |
| CN102038635A (zh) | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
| WO2011064164A1 (fr) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nébuliseur |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2504051B1 (fr) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nébuliseur |
| EP2585151B1 (fr) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Nébuliseur |
| WO2012130757A1 (fr) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Appareil médical pourvu d'un récipient |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (fr) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Pulvérisateur comprenant des moyens de détrompage |
| EP2777691A1 (fr) * | 2013-03-14 | 2014-09-17 | Pharmachemie B.V. | Taxoïde - purification des excipients liquides |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| EP3030298B1 (fr) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nébuliseur |
| US10722666B2 (en) | 2014-05-07 | 2020-07-28 | Boehringer Ingelheim International Gmbh | Nebulizer with axially movable and lockable container and indicator |
| ES2957901T3 (es) | 2014-05-07 | 2024-01-29 | Boehringer Ingelheim Int | Recipiente y dispositivo indicador y nebulizador |
| EP3139979B1 (fr) | 2014-05-07 | 2023-07-05 | Boehringer Ingelheim International GmbH | Unité, nébuliseur et procédé |
| CN103980232A (zh) * | 2014-06-05 | 2014-08-13 | 北京诺普德医药科技有限公司 | 10-乙酰基多西紫杉醇及其用途 |
| DK3307326T3 (da) | 2015-06-15 | 2020-10-19 | Angiochem Inc | Fremgangsmåder til behandling af leptomeningeal karcinomatose |
| TWI752750B (zh) * | 2015-09-30 | 2022-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| CN108066335B (zh) * | 2016-11-11 | 2020-02-21 | 北京康辰药业股份有限公司 | 一种含有紫杉醇或其类似物的药物组合物及其制备方法 |
| FR3113238B1 (fr) | 2020-08-05 | 2024-04-05 | Gattefosse Sas | Utilisation comme excipient, d’un melange de macrogolglyceride laurique et de polyethylene glycol |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5817321A (en) * | 1992-10-08 | 1998-10-06 | Supratek Pharma, Inc. | Biological agent compositions |
| ES2224200T3 (es) * | 1992-11-27 | 2005-03-01 | Mayne Pharma (Usa) Inc. | Composicion inyectable estable de paclitaxel. |
| US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| US6395770B1 (en) * | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
| EA002400B1 (ru) * | 1996-03-12 | 2002-04-25 | Пи Джи-Ти Экс Эл Компани, Л.П. | Водорастворимые пролекарства противоракового действия |
| CA2189916C (fr) * | 1996-11-08 | 2001-01-16 | Parkash S. Gill | Un nouveau regime pour l'administration de paclitaxel a des malades souffrant du sarcoma de kaposi |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| US5980936A (en) * | 1997-08-07 | 1999-11-09 | Alliance Pharmaceutical Corp. | Multiple emulsions comprising a hydrophobic continuous phase |
| CA2328771A1 (fr) * | 1997-12-31 | 1999-07-08 | Bristol-Myers Squibb Company | Analogues de 2-aroyl-4-acyl paclitaxel (taxel) |
| IL131217A0 (en) * | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
| US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| CA2373819A1 (fr) * | 1999-05-17 | 2000-11-23 | Bristol-Myers Squibb Company | Nouvelles conditions de reaction destinees au clivage des silyl-ethers dans la preparation de paclitaxel (taxol) et d'analogues de paclitaxel |
| EP1206461B8 (fr) * | 1999-08-11 | 2004-07-21 | Bristol-Myers Squibb Company | Procédé de préparation d'un analogue carbonate de méthyl C-4 du paclitaxel |
| US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
| US6916942B2 (en) * | 2000-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Process for the preparation of C-4 carbonate taxanes |
| US6750246B1 (en) * | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| TWI310684B (en) * | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
| JP2004536026A (ja) * | 2000-11-28 | 2004-12-02 | トランスフォーム ファーマシューティカルズ，インコーポレーティッド． | パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤 |
| TWI297335B (en) * | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| US20040092428A1 (en) * | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
-
2002
- 2002-12-12 HU HU0500843A patent/HUP0500843A2/hu unknown
- 2002-12-12 CA CA002470826A patent/CA2470826A1/fr not_active Abandoned
- 2002-12-12 BR BRPI0215184-7A patent/BR0215184A/pt not_active IP Right Cessation
- 2002-12-12 RS YU52904A patent/RS52904A/sr unknown
- 2002-12-12 RU RU2004119557/15A patent/RU2004119557A/ru not_active Application Discontinuation
- 2002-12-12 HR HR20040545A patent/HRP20040545A2/xx not_active Application Discontinuation
- 2002-12-12 EP EP02797339A patent/EP1465618A2/fr not_active Withdrawn
- 2002-12-12 KR KR10-2004-7009593A patent/KR20040066921A/ko not_active Withdrawn
- 2002-12-12 WO PCT/US2002/040127 patent/WO2003053350A2/fr not_active Ceased
- 2002-12-12 CN CNB028254708A patent/CN1273130C/zh not_active Expired - Fee Related
- 2002-12-12 GE GE5614A patent/GEP20063806B/en unknown
- 2002-12-12 PL PL02374283A patent/PL374283A1/xx not_active Application Discontinuation
- 2002-12-12 IL IL16211802A patent/IL162118A0/xx unknown
- 2002-12-12 JP JP2003554110A patent/JP2006501134A/ja not_active Withdrawn
- 2002-12-12 AU AU2002361701A patent/AU2002361701A1/en not_active Abandoned
- 2002-12-16 TW TW091136275A patent/TW200302086A/zh unknown
- 2002-12-19 AR ARP020105039A patent/AR037951A1/es unknown
- 2002-12-19 US US10/323,551 patent/US20030220391A1/en not_active Abandoned
- 2002-12-20 UY UY27598A patent/UY27598A1/es not_active Application Discontinuation
-
2003
- 2003-01-06 PE PE2003000013A patent/PE20030742A1/es not_active Application Discontinuation
-
2004
- 2004-06-09 ZA ZA200404584A patent/ZA200404584B/en unknown
- 2004-06-10 IS IS7306A patent/IS7306A/is unknown
- 2004-06-16 MX MXPA04005877A patent/MXPA04005877A/es unknown
- 2004-07-19 NO NO20043101A patent/NO20043101L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY27598A1 (es) | 2003-07-31 |
| TW200302086A (en) | 2003-08-01 |
| PL374283A1 (en) | 2005-10-03 |
| CA2470826A1 (fr) | 2003-07-03 |
| IL162118A0 (en) | 2005-11-20 |
| HUP0500843A2 (hu) | 2005-12-28 |
| GEP20063806B (en) | 2006-04-25 |
| WO2003053350A2 (fr) | 2003-07-03 |
| IS7306A (is) | 2004-06-10 |
| US20030220391A1 (en) | 2003-11-27 |
| HRP20040545A2 (en) | 2005-08-31 |
| AU2002361701A1 (en) | 2003-07-09 |
| RU2004119557A (ru) | 2005-04-20 |
| JP2006501134A (ja) | 2006-01-12 |
| BR0215184A (pt) | 2006-06-06 |
| RS52904A (sr) | 2006-12-15 |
| CN1273130C (zh) | 2006-09-06 |
| AR037951A1 (es) | 2004-12-22 |
| CN1606437A (zh) | 2005-04-13 |
| WO2003053350A3 (fr) | 2004-01-15 |
| KR20040066921A (ko) | 2004-07-27 |
| PE20030742A1 (es) | 2003-09-02 |
| MXPA04005877A (es) | 2004-09-13 |
| EP1465618A2 (fr) | 2004-10-13 |
| ZA200404584B (en) | 2005-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043101L (no) | Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet | |
| CY1115386T1 (el) | Συνδυασμος αζελαστινης και μομεταζονης | |
| NO20076613L (no) | Farmasoytiske formuleringer og anvendelse derav | |
| LU92513I2 (fr) | Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi) | |
| NO20075660L (no) | Blanding for behandling av inflammatoriske sykdommer | |
| NO2012006I1 (no) | Telaprevir og enhver terapeutisk ekvivalent form derav som er beskyttet av basispatentet, slik som farmasøytisk akseptable salter og/eller solvater avtelaprevir eller solvater av slike salter | |
| NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
| NO20035438L (no) | Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav | |
| DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
| CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
| SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
| CO5590918A2 (es) | Formulaciones | |
| DK1675591T3 (da) | Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer | |
| CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
| EP1574215A4 (fr) | Medicament solide administre par voie orale | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| DK1212312T3 (da) | Hidtil ukendte derivater af flavoner, xanthoner og coumariner | |
| EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
| DK1379508T3 (da) | N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf | |
| DK1992338T3 (da) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
| NO20043314L (no) | Sedative non-benzodiazepinformuleringer | |
| WO2004062564A3 (fr) | Formulations non-benzodiazepine sedatives | |
| DK1499278T3 (da) | Farmaceutisk doseringsform, som udviser umiddelbar frigivelse, og som omfatter polymorf tibolon | |
| EA200602199A1 (ru) | Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство | |
| CY1106129T1 (el) | Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |